跳至主要内容
临床试验/JPRN-UMIN000023681
JPRN-UMIN000023681已完成未知

Evaluation of efficiency and safety of dapagliflozin in treating of type 2 diabetes mellitus - Efficiency and safety of dapagliflozin

Juntendo University Urayasu Hospital0 个研究点目标入组 30 人开始时间: 2016年8月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Type 1 diabetes mellitus 2.Diabetic ketoacidosis, diabetic coma, or before coma 3.Sever infection, before and not long after surgery, or patients with sever trauma 4.Left ventricular dysfunction (EF < 50%) 5.Sever liver dysfunction 6.Past history of cerebral infarction, myocardial infarction, and sever heart failure 7.Women suspected of pregnancy or pregnant 8.Patients with a history of use SGLT2 inhibitors 9.Patients who have repeated urinary tract infections 10.Alchole intake excessive 11.Inadequate patients judged by doctor

研究者

相似试验